Identificación de predictores genómicos de la conducción atrioventricular: el uso de registros médicos electrónicos

Joshua C Denny1, Marylyn D Ritchie, Dana C Crawford

  • 1Office of Personalized Medicine, Vanderbilt University School of Medicine, Nashville, TN 37232-0575, USA.

Circulation
|November 3, 2010
PubMed
Resumen

Este estudio de asociación de todo el genoma identificó las variantes del gen SCN10A que influyen en la duración del intervalo de PR en los estadounidenses de origen europeo. Los registros médicos electrónicos apoyan el análisis genotipo-fenotipo para la fisiopatología cardíaca.

Videos de Conceptos Relacionados

Electrocardiogram01:29

Electrocardiogram

An electrocardiogram (ECG or EKG) is a critical diagnostic tool that records the electrical signals produced by the heart during each heartbeat. This recording is achieved through electrodes placed strategically on the arms, legs, and chest. The electrocardiograph amplifies these signals and produces 12 distinct tracings, offering a comprehensive understanding of the heart's electrical activity.
Three major waveforms are present in a typical ECG recording: the P wave, the QRS complex, and the T...
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...